PET measurement of changes in D2/D3 dopamine receptor binding in a nonhuman primate during chronic deep brain stimulation of the bed nucleus of the stria terminalis

Journal of Neuroscience Methods

Volumn 176, Issue 2, 2009, Pages 129-135

  Vandehey, Nicholas T ^a   Garell, P Charles ^b   Hampel, Joseph A ^c   Murali, Dhanabalan ^c   Smith, Elizabeth M ^a   Davidson, Richard ^c   Converse, Alexander K ^c   Nickles, R Jerry ^a   Christian, Bradley T ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

BNST; D2 D3; DBS; Deep brain stimulation; Dopamine; Fallypride; PET

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FLUORINE 18;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DISTRIBUTION VOLUME; IMAGE ANALYSIS; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; RHESUS MONKEY; STRIA TERMINALIS;

ANIMALS; BENZAMIDES; BIOPHYSICS; BRAIN; BRAIN MAPPING; DEEP BRAIN STIMULATION; DOPAMINE ANTAGONISTS; MACACA MULATTA; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SEPTAL NUCLEI; TIME FACTORS;

EID: 57649178918     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2008.08.033     Document Type: Article

References (43)

1. Abosch A., Kapur S., Lang A.E., Hussey D., Sime E., Miyasaki J., et al. Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Neurosurgery 53 (2003) 1095-1105
2. Alpert N., Badgaiyan R., Livni E., and Fischman A. A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems. NeuroImage 19 (2003) 1049-1060
3. Bina K.G., and Cincotta A.H. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology 71 (2000) 68-78
4. Christian B.T., Narayanan T.K., Shi B., and Mukherjee J. Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [18F]fallypride in nonhuman primates. Synapse 38 (2000) 71-79
5. Christian B.T., Narayanan T., Shi B., Morris E.D., Mantil J., and Mukherjee J. Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol. J Cereb Blood Flow Metab 24 (2004) 309-322
6. Dewey S.L., Smith G.S., Logan J., Brodie J.D., Yu D.W., Ferrieri R.A., et al. GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. J Neurosci 12 (1992) 3773-3780
7. Fudge J.L., and Haber N. Bed nucleus of the stria terminalis and extended amygdala inputs to dopamine subpopulation in primates. Neuroscience 104 (2001) 807-827
8. Fukuda M., Mentis M.J., Ma Y., Dhawan V., Antonini A., Lang A.E., et al. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. Brain 124 (2001) 1601-1609
9. Ginovart N., Farde L., Halldin C., and Swahn C.G. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain. Synapse 25 (1997) 321-325
10. Hamani C., McAndrews M.P., Cohn M., Oh M., Zumsteg D., Shapiro C.M., et al. Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Ann Neurol 63 (2008) 119-123
11. Haslinger B., Kalteis K., Boecker H., Alesch F., and Ceballos-Baumann A.O. Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease. Neuroimage 28 (2005) 598-606
12. Hilker R., Voges J., Ghaemi M., Lehrke R., Rudolf J., Koulousakis A., et al. Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Mov Disord 18 (2003) 41-48
13. Hilker R., Voges J., Weisenbach S., Kalbe E., Burghaus L., Ghaemi M., et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 24 (2004) 7-16
14. Ichise M., Liow J.S., Lu J.Q., Takano A., Model K., Toyama H., et al. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23 (2003) 1096-1112
15. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27 (2007) 1533-1539
16. King B.M. Amygdaloid lesion-induced obesity: relation to sexual behavior, olfaction, and the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol 291 (2006) 1201-1214
17. Lacan G., De Salles A.A.F., Gorgulho A., Krahl S.E., Frighetto L., Behnke E.J., et al. Modulation of food intake following deep brain stimulation of the ventromedial hypothalamus in the vervet monkey. J Neurosurg 108 (2008) 336-342
18. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical revew. J Cereb Blood Flow Metab 20 (2000) 423-451
19. Leone M., Franzini A., Broggi G., and Bussone G. Expanding the role of deep brain stimulation from movement disorders to other neurological diseases. In: Freese A., Simeone F.A., Leone P., and Janson C. (Eds). Principles of Molecular Neurosurgery (2005), Karger, Basel 270-283
20. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 45 (2005) 651-660
21. McIntyre C.C., Savasta M., Walter B.L., and Vitek J.L. How does deep brain stimulation work? Present understanding and future questions. J Clin Neurophysiol 21 (2004) 40-50
22. Montgomery E.B., and Gale J.T. Mechanisms of action of deep brain stimulation (DBS). Neurosci Biobehav Rev 32 (2008) 388-407
23. Moro E., Esselin R.J.A., Hommel M., and Benabid A.L. The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology 59 (2002) 706-713
24. Morris E.D., Normandin M.D., and Schiffer W.K. Initial comparison of ntPET with microdialysis measurements of methamphetamine-induced dopamine release in rats: support for estimation of dopamine curves from PET data. Mol Imaging Biol 10 (2008) 67-73
25. Mukherjee J., Yang Z.Y., Brown T., Lew R., Wernick M., Ouyang X., et al. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride. Nucl Med Biol 26 (1999) 519-527
26. Nader M.A., and Czoty P.W. Brain imaging in nonhuman primates: insights into drug addiction. ILAR J 49 (2008) 89-102
27. Nader M.A., Grant K.A., Gage H.D., Ehrenkaufer R.L., Kaplan J.R., and Mach R.H. PET imaging of dopamine D2 receptors with [18F]fluoroclebopride in monkeys: effects of isoflurane- and ketamine-induced anesthesia. Neuropsychopharmacol 21 (1999) 589-596
28. Nimura T., Yamaguchi K., Ando T., Shibuya S., Oikawa T., Nakagawa A., et al. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study. J Neurosurg 103 (2005) 968-973
29. Norgren R., Hajnal A., and Mungarndee S.S. Gustatory reward and the nucleus accumbens. Physiol Behav 89 (2006) 531-535
30. Paxinos G., Huang X.F., and Toga A.W. The rhesus monkey brain in sterotaxic coordinates (2000), Academic Press, San Diego
31. Perlmutter J.S., and Mink J.W. Deep brain stimulation. Annu Rev Neurosci 29 (2006) 229-257
32. Perlmutter J.S., Mink J.W., Bastian A.J., Zackowski K., Hershey T., Miyawaki E., et al. Blood flow responses to deep brain stimulation of thalamus. Neurology 58 (2002) 1388-1394
33. Rollins B.L., Stines S.G., and King B.M. Role of stria terminalis in food intake and body weight in rats. Physiol Behav 89 (2006) 139-145
34. Sani S., Jobe K., Smith A., Kordower J.H., and Bakay R.A.E. Deep brain stimulation for treatment of obesity in rats. J Neurosurg 107 (2007) 809-813
35. Schlaepfer T., Cohen M., Frick C., Kosel M., Brodesser D., Axmacher N., et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33 (2007) 368-377
36. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 Suppl. 1 (2004) 208-219
37. Strafella A.P., Sadikot A.F., and Dagher A. Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease. Neuroreport 14 (2003) 1287-1289
38. Tai C., Chatziioannou A., Siegel S., Young J., Newport D., Goble R.N., et al. Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. Phys Med Biol 46 (2001) 1845-1862
39. Tepper, J.M., Diana, M., Electrophysiological pharmacology of mesenchephalic dopaminergic neurons In: Chiara, editor. Dopamine in the CNS II. Springer, Berlin, Heidelberg, New York; 2002 [Chapter 13].
40. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., et al. Brain dopamine and obesity. Lancet 357 (2001) 354-357
41. Wang G., Volkow N.D., and Fowler J.S. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets 6 (2002) 601-609
42. Windels F., Bruet N., Poupard A., Feuerstein C., Bertrand A., and Savasta M. Influence of the frequency parameter on extracellular glutamate and γ-aminobutyric acid in substantia nigra and globus pallidus during electrical stimulation of subthalamic nucleus in rats. J Neurosci Res 72 (2003) 259-267
43. Woods R.P., Grafton S.T., Holmes C.J., Cherry S.R., and Mazziotta J.C. Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 22 (1998) 139-152